These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 170532)

  • 21. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.
    Creese I
    Eur J Pharmacol; 1974 Sep; 28(1):55-8. PubMed ID: 4473347
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.
    Gianutsos G; Drawbaugh RB; Hynes MD; Lal H
    Life Sci; 1974 Mar; 14(5):887-98. PubMed ID: 4828404
    [No Abstract]   [Full Text] [Related]  

  • 24. LSD as an agonist of dopamine receptors in the striatum.
    Pieri L; Pieri M; Haefely W
    Nature; 1974 Dec; 252(5484):586-8. PubMed ID: 4431521
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers.
    Costall B; Naylor RJ; Nohria V; Owen RT
    J Pharm Pharmacol; 1978 Oct; 30(10):657-60. PubMed ID: 30826
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypothermic effect of apomorphine in the mouse.
    Fuxe K; Sjöqvist F
    J Pharm Pharmacol; 1972 Sep; 24(9):702-5. PubMed ID: 4404073
    [No Abstract]   [Full Text] [Related]  

  • 29. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive.
    Staunton DA; Magistretti PJ; Koob GF; Shoemaker WJ; Bloom FE
    Nature; 1982 Sep; 299(5878):72-4. PubMed ID: 7110328
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo interaction of haloperidol and apomorphine.
    Niemegeers CJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):43-50. PubMed ID: 747463
    [No Abstract]   [Full Text] [Related]  

  • 33. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of apomorphine and haloperidol on memory consolidation in the day-old chick.
    Hale MW; Crowe SF
    Behav Neurosci; 2001 Apr; 115(2):376-83. PubMed ID: 11345962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine.
    Strömbom U
    J Neural Transm; 1977; 40(3):191-4. PubMed ID: 874471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apomorphine-induced hypothermia in mice; a possible dopaminergic effect.
    Barnett A; Goldstein J; Taber RI
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):242-7. PubMed ID: 5054733
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine hypothermia: interaction with serotonergic agents.
    Kulkarni SK
    Pol J Pharmacol Pharm; 1980; 32(1):15-20. PubMed ID: 7192860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.